Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights March 24, 2026 COMP360 is the first classic psychedelic1 to consistently achieve a highly statistically significant result and clinically meaningful effect in treatment resistant depression (TRD), with a generally well-tolerated and safe profile Across three large trials in TRD, including two positive Phase 3 studies, COMP360’s differentiated profile is redefining rapidity and durability for TRD patients and demonstrating a consistent level of clinical effect that has never been achieved before Compass will meet with the FDA to confirm alignment on a rolling submission and review, and expects to complete the NDA submission in Q4 Compass is rapidly advancing commercial readiness plans and expects COMP360 will fit seamlessly across diverse healthcare settings at launch Phase 2b/3 trial in PTSD initiating, following FDA acceptance of IND application Successful $150 million financing in February and exercise of $200 million in warrants extends cash runway into 2028
Kolibri Global Energy Announces Year End Results With a 15% Increase in Production to Over 4,013 BOEPD March 19, 2026 All amounts are in U.S. Dollars unless otherwise indicated: 2025 HIGHLIGHTS Average production for 2025 was 4,013 BOEPD, an increase of 15% compared to 2024 production of 3,478 BOEPD. The increase is due to production from the wells that were drilled and completed in 2025 Net revenues for 2025 were $56.9 million, a decrease of [...]
TITAN Group: Full Year Results 2025 March 19, 2026 Very strong performance delivers another record year
Kolibri Global Energy Inc. Announces 2025 Proved Developed Reserve Increase of 30% and Year End Earnings Call March 18, 2026 Kolibri Global Energy Inc. (the “Company” or “KGEI”) (TSX: KEI, NASDAQ: KGEI) is providing the results of its December 31, 2025, independent reserves evaluation. All amounts are in US$ unless otherwise stated. Wolf Regener, President and CEO, commented: “We are very pleased that our proved developed producing reserves increased by 30 percent due to our [...]
REPLY: The Board of Directors Approved the Draft Financial Statements for the Year 2025 March 12, 2026 All economic indicators are positive. Consolidated turnover of €2,483.6 million (€2,300.5 million in 2024); EBITDA at €467.6 million (€410.6 million in 2024); EBIT at €391.7 million (€330.4 million in 2024) Group net profit at €250.9 million (€211.1 million in 2024) Approval of the proposed dividend distribution of €1.35 per share.
Argan, Inc. to Announce Fourth Quarter and Fiscal Year-End 2026 Results and Host Conference Call on Thursday, March 26, 2026 March 12, 2026 Argan, Inc. (NYSE: AGX) (“Argan” or the “Company”) today announced that the Company will release its fourth quarter and fiscal year-end 2026 financial results after the market closes on Thursday, March 26, 2026. Management will host a webcast with an accompanying slide presentation and conference call on Thursday, March 26, 2026 at 5:00 p.m. ET. [...]
Silence Therapeutics Highlights Recent Business Achievements and Reports Fourth Quarter and Full Year 2025 Financial Results March 5, 2026 Topline results for Phase 2 SANRECO trial of divesiran, a first-in-class siRNA for polycythemia vera (PV), on-track for third quarter of 2026
Algoma Central Corporation Reports Financial Results for Fiscal 2025 March 5, 2026 Strong momentum continues in 2025 through resilient performance and strategic fleet growth across global and domestic markets
Techtronic Industries Delivers Solid Performance in 2025 March 3, 2026 Growing Sales to US$15.3 Billion, Net Profit Increased to US$1.2 Billion
RHI Magnesita 2025 Full Year Results: Disciplined Execution and Strong H2 Performance Deliver Resilient Earnings in Challenging Market Environment March 2, 2026 RHI Magnesita, the leading global supplier of high-grade refractory products, systems and solutions, announces its results for the year ended 31 December 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302341332/en/ A resilient financial performance – in line with expectations Against a challenging market backdrop, RHI Magnesita delivered a performance in line [...]